National Policy for Rare Disease (NPRD) 2021

30.07.2024

National Policy for Rare Disease (NPRD) 2021

Why in the news?                                                                                                                                                                                                 

             Only four out of twelve Centres of Excellence (CoEs) for rare diseases have utilized funds provided to them by the Government under the National Policy for Rare Disease (NPRD) in the last three years, according to patient advocacy groups.

About National Policy for Rare Disease (NPRD):

• The Ministry of Health and Family Welfare, Government of India, has launched the National Policy for Rare Diseases (NPRD) in March 2021, for the management of patients having rare diseases, which is directed towards prevention, early detection, and treatment of such diseases.
• The policy has provision of free treatment facilities for persons suffering with such diseases at designated ‘Centres of Excellence’.
• The salient features of NPRD 2021 are as under:

●The rare diseases have been identified and categorized into 3 groups:

○Group 1: Disorders amenable to one-time curative treatment.

○Group-2: Diseases requiring long term/lifelong treatment having relatively lower cost of treatment and benefit have been documented in literature, and annual or more frequent surveillance is required.

○Group 3: Diseases for which definitive treatment is available but challenges are to make optimal patient selection for benefit, very high cost, and lifelong therapy.

• Centers of Excellences (CoEs) have been identified for the diagnosis, prevention, and treatment of rare diseases.

●These COEs will be provided a one-time grant subject to a maximum of Rs 5 crore each for infrastructure development for screening, tests, and treatment, if such infrastructure is not available.

• Provision for financial support of up to Rs. 50 lakhs to the patients suffering from any category of the Rare Diseases and for treatment in any of the CoE mentioned in NPRD-2021, outside the Umbrella Scheme of Rashtriya Arogya Nidhi (RAN).

○RAN provides a one-time financial assistance to poor patients living below State/UT wise threshold poverty line suffering from rare diseases (RD) listed under group 1 for treatment at Government hospitals/institutes having Super Specialty facilities; (Maximum financial assistance is Rs. 20 lakhs).

• In order to receive financial assistance for treatment of a rare disease, the patient of the nearby area may approach the nearest CoE to get him assessed and avail the benefits.
• Treatment of patients starts immediately after registration with the CoEs.
• Nidan Kendras have been set up for genetic testing and counseling services.
• It has provisions for promotion of research and development for diagnosis and treatment of rare diseases; promotion of local development and manufacture of drugs and creation of a conducive environment for indigenous manufacturing of drugs for rare diseases at affordable prices.

                                                            Source: Business standard

Ques :- Consider the following statements regarding National Policy for Rare Disease (NPRD) 2021:

Statement-I

It has provision for financial support of up to Rs. 50 lakhs to the patients suffering from rare diseases.

Statement-II

 It has provisions for the promotion of research and development for diagnosis and treatment of rare diseases.

Which one of the following is correct in respect of the above statements?

A.Both Statement-I and Statement-II are correct, and Statement-II is the correct explanation for Statement-I.

B.Both Statement-I and Statement-II are correct, and Statement-II is not the correct explanation for Statement-I.

C.Statement-I is correct, but Statement-II is incorrect.

D.Statement-I is incorrect, but Statement-II is correct.

Answer A